Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M E Cooper

Showing results (91-100 of 246) with videos related to

Pageof 25
Sort By:
The Medical Journal of Australia|February 24, 2001
Defining moments in medicine. Internal medicineC I Johnston, M E Cooper, A J Taylor, et al.
Journal of Hypertension|June 14, 2001
Vascular expression of angiotensin type 2 receptor in the adult rat: influence of angiotensin II infusionF Bonnet, M E Cooper, R M Carey, et al.
Journal of Dental Research|April 13, 2012
Defining predictors of cleft lip and palate riskM Yildirim, F Seymen, K Deeley, et al.
Journal of Diabetes and Its Complications|October 1, 1995
Extracellular matrix and its interactions in the diabetic kidney: a molecular biological approachR E Gilbert, A Cox, M Dziadek, et al.
Current Drug Targets|July 20, 2005
The role of AGEs and AGE inhibitors in diabetic cardiovascular diseaseM C Thomas, J W Baynes, S R Thorpe, et al.
Atherosclerosis|April 17, 1998
Aminoguanidine has an anti-atherogenic effect in the cholesterol-fed rabbitS Panagiotopoulos, R C O'Brien, R Bucala, et al.
British Medical Journal (Clinical Research Ed.)|December 6, 1986
Phaeochromocytoma in the elderly: a poorly recognised entity?M E Cooper, D Goodman, A Frauman, et al.
Hypertension (Dallas, Tex. : 1979)|September 1, 1995
Amylin stimulates plasma renin concentration in humansM E Cooper, P G McNally, P A Phillips, et al.
The Medical Journal of Australia|October 2, 1995
Diabetes and hypertension. Australian Diabetes Society position statementR E Gilbert, M Jasik, M DeLuise, et al.
Journal of Hypertension|December 18, 1998
Angiotensin converting enzyme inhibition reduces the expression of transforming growth factor-beta1 and type IV collagen in diabetic vasculopathyJ R Rumble, R E Gilbert, A Cox, et al.
Pageof 25

Showing results (91-100 of 246) with videos related to

Sort By:
Pageof 25
The Medical Journal of Australia|February 24, 2001
Defining moments in medicine. Internal medicineC I Johnston, M E Cooper, A J Taylor, et al.
Journal of Hypertension|June 14, 2001
Vascular expression of angiotensin type 2 receptor in the adult rat: influence of angiotensin II infusionF Bonnet, M E Cooper, R M Carey, et al.
Journal of Dental Research|April 13, 2012
Defining predictors of cleft lip and palate riskM Yildirim, F Seymen, K Deeley, et al.
Journal of Diabetes and Its Complications|October 1, 1995
Extracellular matrix and its interactions in the diabetic kidney: a molecular biological approachR E Gilbert, A Cox, M Dziadek, et al.
Current Drug Targets|July 20, 2005
The role of AGEs and AGE inhibitors in diabetic cardiovascular diseaseM C Thomas, J W Baynes, S R Thorpe, et al.
Atherosclerosis|April 17, 1998
Aminoguanidine has an anti-atherogenic effect in the cholesterol-fed rabbitS Panagiotopoulos, R C O'Brien, R Bucala, et al.
British Medical Journal (Clinical Research Ed.)|December 6, 1986
Phaeochromocytoma in the elderly: a poorly recognised entity?M E Cooper, D Goodman, A Frauman, et al.
Hypertension (Dallas, Tex. : 1979)|September 1, 1995
Amylin stimulates plasma renin concentration in humansM E Cooper, P G McNally, P A Phillips, et al.
The Medical Journal of Australia|October 2, 1995
Diabetes and hypertension. Australian Diabetes Society position statementR E Gilbert, M Jasik, M DeLuise, et al.
Journal of Hypertension|December 18, 1998
Angiotensin converting enzyme inhibition reduces the expression of transforming growth factor-beta1 and type IV collagen in diabetic vasculopathyJ R Rumble, R E Gilbert, A Cox, et al.
Pageof 25